Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-13-002703)

Filing Details

Accession Number:: 0001209191-13-002703
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-01-09 17:00:38
Reporting Period:: 2013-01-07

Filing Date:: 2013-01-09
Accepted Time:: 2013-01-09 17:00:38
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1292519	Invivo Therapeutics Holdings Corp.	NVIV	Surgical & Medical Instruments & Apparatus (3841)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1503383	Francis Reynolds	C/O Invivo Therapeutics Holdings Corp. One Kendall Square, Suite B14402 Cambridge MA 02139	Ceo, Cfo	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2013-01-07	2,000	$1.90	14,290,660	No	4	S	Direct
Common Stock	Disposition	2013-01-07	2,250	$1.96	14,288,410	No	4	S	Direct
Common Stock	Disposition	2013-01-08	1,000	$2.06	14,287,410	No	4	S	Direct
Common Stock	Disposition	2013-01-08	1,000	$2.07	14,286,410	No	4	S	Direct
Common Stock	Disposition	2013-01-08	2,250	$2.12	14,284,160	No	4	S	Direct
Common Stock	Disposition	2013-01-09	2,000	$2.17	14,282,160	No	4	S	Direct
Common Stock	Disposition	2013-01-09	2,250	$2.25	14,279,910	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	13,603	Indirect	By 401(k) Plan

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 4, 2012.